Skip to main content

Table 1 Clinical and demographic characteristics of patients with UESL. GTR: Gross tumor resection

From: Clinicopathological study of hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a single center study from Iran

Patient

Age

Sex

Tumor Location

Extrahepatic Metastasis

Symptoms

COG Stage

Laboratory Findings

CT Imaging Findings

Surgery

Radiation Therapy

Chemotherapy

Recurrence

Outcome (years from diagnosis

Case 1

2y 8 M

M

Right lobe

–

Abdominal pain, Fever

I

↑ AST, ALT

Lobulated hypodense mass with peripheral irregularity and focal calcification

GTR

–

+ (Vincristine, Actinomycin, Cyclophosphamide, Doxorubicin, Ifosfamide, Etoposide)

–

No evidence of disease (8y)

Case 2

14y

F

Right lobe

–

Abdominal pain, anorexia, weight loss

I

↑Plt, ↓Hb

Heterogeneous lesion with intratumoral hemorrhage and multiple foci of necrosis

GTR

–

+

–

No evidence of disease (6y)

Case 3

13y

F

Right lobe

–

Abdominal pain, nausea/vomiting

I

↑CA-125

Hypodense lesion with faint peripheral and internal septation

GTR

–

–

–

No evidence of disease (6y)

Case 4

12y

F

Right lobe

–

Abdominal pain

III

↓Hb

Cystic mass with solid nodules and septation

GTR

+

+

+

Died of disease (3y)

Case 5

3y 6 M

M

Right lobe

–

Abdominal pain

I

↑INR, ↓ Hb

Complicated hypoattenuated mass containing septation

GTR

–

+ (Actinomycin, Cyclophosphamide, Vincristine)

–

No evidence of disease (3.5y)

Case 6

12 y

F

Right lobe

–

Abdominal pain, nausea/vomiting

I

↑ AST, ALT

Hypoattenuating lesion with multiple thick septa

GTR

+

+

+

Under treatment (3y)

Case 7

5 y

M

Right lobe

–

Abdominal pain, nausea/vomiting

I

↑ AST, ALT

Cystic mass with internal septation

GTR

–

+ (Vincristine, Doxorubicin, Cyclophosphamide)

–

No evidence of disease (2y)

Case 8

16 y

F

Right lobe

–

Abdominal pain, chills, fever

II

↑INR, ↑ ESR, ↓ Hb

Heterogenous hypodense mass

GTR

–

+

–

No evidence of disease (1y)